MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 13.01.2026
Bio-Path Holdings EV/EBITDA 2011-2026 | BPTH
EV/EBITDA Jährlich Bio-Path Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.24 | -0.17 | 0.407 | -0.0267 | -2.01 | -9.29 | -22.1 | -43 | -99 | -8.19 | -5.81 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.407 | -99 | -17.2 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M |  Germany |
 |
Graybug Vision
GRAY
|
-0.336 | - | -11.23 % | $ 9.65 M |  USA |
 |
AbCellera Biologics
ABCL
|
9.24 | $ 3.64 | -1.89 % | $ 1.09 B |  Canada |
 |
ADMA Biologics
ADMA
|
-4.17 | $ 16.45 | 0.43 % | $ 3.92 B | USA |
 |
I-Mab
IMAB
|
595 | - | - | $ 866 M |  China |
 |
ANI Pharmaceuticals
ANIP
|
109 | $ 76.75 | 0.85 % | $ 1.48 B | USA |
 |
Apellis Pharmaceuticals
APLS
|
-6.39 | $ 19.93 | -1.14 % | $ 2.51 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | USA |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | USA |
 |
Aptorum Group Limited
APM
|
29.4 | $ 0.83 | 4.23 % | $ 4.53 M | China |
 |
Athersys
ATHX
|
0.437 | - | 3.77 % | $ 22.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
-1.76 | - | - | $ 521 M | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
-5.59 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
8 | - | -4.8 % | $ 255 M | USA |
 |
Axsome Therapeutics
AXSM
|
-8.03 | $ 163.82 | -0.14 % | $ 8.15 B | USA |
 |
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | USA |
 |
BridgeBio Pharma
BBIO
|
-4.37 | $ 66.98 | 3.8 % | $ 12.8 B | USA |
 |
CymaBay Therapeutics
CBAY
|
-1.63 K | - | - | $ 3.45 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
Avid Bioservices
CDMO
|
109 | - | - | $ 789 M | USA |
 |
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
-0.833 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
0.677 | - | -16.75 % | $ 25.8 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | USA |
 |
BioLineRx Ltd.
BLRX
|
-53.5 | $ 2.88 | 2.51 % | $ 908 M |  Israel |
 |
Clovis Oncology
CLVS
|
-3.86 | - | -7.23 % | $ 13 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | USA |
 |
BioMarin Pharmaceutical
BMRN
|
671 | $ 60.75 | 3.79 % | $ 11.7 B | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.0315 | - | - | $ 231 M | USA |
 |
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | Canada |
 |
CTI BioPharma Corp.
CTIC
|
-0.985 | - | - | $ 1.2 B | USA |
 |
CohBar
CWBR
|
0.216 | - | -15.44 % | $ 2.2 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
0.195 | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.975 | - | -4.36 % | $ 27 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-1.5 | - | - | $ 2.18 B | USA |
 |
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | Canada |
 |
Cabaletta Bio
CABA
|
0.778 | $ 3.41 | 4.77 % | $ 3.98 M | USA |
 |
Capricor Therapeutics
CAPR
|
-2.14 | $ 25.71 | -0.5 % | $ 688 M | USA |
 |
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
Codexis
CDXS
|
-100 | $ 1.1 | 12.24 % | $ 80.7 M | USA |
 |
Certara
CERT
|
256 | $ 7.33 | 1.24 % | $ 1.18 B | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
-0.397 | - | - | $ 105 M | USA |
 |
Evofem Biosciences
EVFM
|
-5.55 | - | 7.55 % | $ 38.1 M | USA |